China (Mainland)
Assessedsupplier 
Eptifibatide CAS NO.188627-80-7
- Min.Order: 1 Gram
- Payment Terms: T/T,MoneyGram,Other
- Product Details
Keywords
- Eptifibatide acetate salt
- 188627-80-7
- 99% purity
Quick Details
- ProName: Eptifibatide
- CasNo: 188627-80-7
- Molecular Formula: C35H49N11O9S2
- Appearance: powder
- Application: Intermediate
- DeliveryTime: large stock
- PackAge: According to the need to packing
- Port: Shanghai
- ProductionCapacity: 100 Kilogram/Month
- Purity: 98% purity
- Storage: sealed,dry,low temperature
- Transportation: air,sea and courier
- LimitNum: 1 Gram
- Grade: Industrial Grade,Pharma Grade,Electron...
Superiority
Eptifibatide Basic information
Product Name: Eptifibatide
Synonyms: Eptifibatide acetate salt;Eptifibatide,MPA-HAR-Gly-Asp-Trp-Pro-Cys-NH2,MPAHARGDWPC-NH2, >99%;MAP-LYS-GLY-ASP-TRP-PRO-CYS-NH2;INTEGRELIN;Eptifibatide;N6-(Aminoiminomethyl)-N2-(3-mercapto-1-oxopropyl-L-lysylglycyl-L-a-aspartyl-L-tryptophyl-L-prolyl-L-cysteinamide;MPA-HAR-GLY-ASP-TRP-PRO-CYS-NH2(DISULFIDE BRIDGE, MPA1-CYS6);Intrifiban
CAS: 188627-80-7
MF: C35H49N11O9S2
MW: 831.96
EINECS: 641-366-7
Product Categories:
Mol File: 188627-80-7.mol
Details
Eptifibatide Chemical Properties
density 1.60±0.1 g/cm3(Predicted)
storage temp. Sealed in dry,Store in freezer, under -20°C
pka 4.01±0.10(Predicted)
CAS DataBase Reference 188627-80-7
Safety Information
Hazardous Substances Data 188627-80-7(Hazardous Substances Data)
Uses A Arginin-glycin-aspartat-mimetic, reversibly binds to platelets to reduce the risk of cardiac ischemic events.
Uses An arginine-glycine-aspartate-mimetic, reversibly binds to platelets to reduce the risk of cardiac ischemic events.
Definition ChEBI: A synthetic homodetic cyclic peptide comprising Nalpha-(3-sulfanylpropanoyl)homoarginyl, glycyl, aspartyl, tryptophyl, prolyl and cysteinamide residues connected in sequence and cyclised via a disulf de bond. Derived from a protein found in the venom of the southeastern pygmy rattlesnake, Sistrurus miliarus barbouri, eptifibatide is an anti-coagulant that inhibits platelet aggregation by selectively blocking the platelet glycoprotein IIb/I Ia receptor, so preventing the binding of fibrinogen, von Willebrand factor, and other adhesive ligands. It is used in the management of unstable angina and in patients undergoing coronary angioplasty and stenting procedures.